News & Analysis on Clinical Trial Services & Contract Research And Development
Britain's Department of Health has awarded healthcare company Baxter and biotech firm Chiron two contracts worth £33m (€48m) in total for the production of around 3.5m doses of H5N1 influenza vaccine, underlying how worldwide concerns about bird flu...
In-PharmaTechnologist Special Report
The rejection by the European Medicines Agency (EMEA) of ATryn has given the biotech industry some unappetising food for thought.
California-based Electronic Sensor Technology, provider of fast vapor analyzers, is benefiting from recent restrictions in California Air Quality and Nuisance Odor laws that require bad-odor-causing industries to measure and control their emissions.
French firms PCAS and Proteus have decided to pool their expertise to create a new biotech company which will provide APIs and intermediates on a large scale, looking to offer new products and also capitalise on the growing demand for generics.
Millipore, a maker of purification systems used in drug manufacturing, has expanded its range of hydrophilic Polytetrafluoroethylene (PTFE) membranes, enabling it to offer filters for virtually all solvents, acids, and alkaline solutions.
West Pharmaceutical Services reported a sales increase of 28 per cent to $700m (€590m) in 2005, boosted by $100m worth of new business.